Rivanna Medical

Rivanna Medical

Healthcare Operations & Administration

About Rivanna Medical

RIVANNA is a commercial-stage medical technology company headquartered in Charlottesville, Virginia, developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company's platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities. RIVANNA's first applications target significant market opportunities in regional anesthesia and fracture care. The company's flagship products include the Accuro 3S platform with SpineNav-AI software for spinal procedures and neuraxial anesthesia, and the Accuro XV system for musculoskeletal imaging and fracture detection. Both platforms leverage proprietary technologies including BoneEnhance Multi-Frequency Image Reconstruction for optimized bone visualization and automated image acquisition techniques. RIVANNA operates an FDA-registered, ISO 13485:2016-certified manufacturing facility and has built a strong intellectual property portfolio with over 100 issued and pending patents worldwide. The company serves healthcare providers in hospital and clinical settings, with a focus on anesthesiology, emergency medicine, and point-of-care diagnostics. RIVANNA's technology addresses longstanding challenges in ultrasound-guided procedures by enabling hands-free operation, automated anatomical landmark detection, and real-time needle guidance, making advanced imaging capabilities more accessible to clinicians.

Mission & Story

Mission

RIVANNA is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company's platform automates complex anatomical analysis at the point of care, enabling faster, more confident clinical decisions while reducing variability and expanding access to advanced capabilities.

Clinical Focus

Medical conditions and clinical areas addressed by Rivanna Medical.

Neuraxial anesthesia proceduresRegional anesthesiaExtremity fracturesBlast-related injuriesMusculoskeletal injuriesSpinal proceduresEpidural space visualization

Who It Serves

HospitalsClinical settingsAcademic medical centersEmergency departmentsAnesthesiology departments

Milestones & Awards

Recent Milestones

FDA 510(k) clearance for Accuro 3S platform and SpineNav-AI software (July 2025). FDA 510(k) clearance for Accuro XV system (2026). Selected as MedTech Innovator 2025 Accelerator finalist (top 4% of 1,500 global applicants). Expanded clinical program to eight academic medical centers. 100th patent filing achieved (2026). BARDA partnership continuation for AI-powered fracture detection module.

Awards & Recognition

MedTech Innovator 2025 Accelerator - Top 4% of 1,500 global applicants, finalist in Early-Stage Grand Prize competition. Nominated for MedTech Scale-Up of the Year at MedTech World Awards 2026 North America.

Key Partnerships

BARDA (Biomedical Advanced Research and Development Authority)Duke University (exclusive patent license)Tri-anim (U.S. distribution alliance)Eight academic medical centers for clinical studies

Company Details

Headquarters
Charlottesville, VA, USA

Work here?

Claim this listing to update company information and connect with our audience.

Claim This Listing

Security & Compliance

FDA 510(k)ISO 13485:2016
Last updated Jul 1, 2026

Similar Companies in this Market

View all 70
AdvancedMD

AdvancedMD

AdvancedMD provides cloud-based practice management, EHR, and patient engagement software for healthcare practices. The company offers an integrated suite of applications including billing, scheduling, telehealth, and revenue cycle management services for independent practices, large groups, and medical billing companies.

Aidin

Aidin

Aidin provides a digital referral management and care coordination platform for hospitals, healthcare systems, and post-acute care providers. The platform streamlines discharge planning, prior authorization, and patient transitions to reduce length of stay, lower readmissions, and improve operational efficiency.

AKASA

AKASA

AKASA provides generative AI solutions for healthcare revenue cycle management, helping health systems reduce denials, improve margins, and increase revenue through AI-powered coding optimization, clinical documentation improvement, and automated administrative workflows.

Anterior

Anterior

Anterior provides enterprise-grade AI solutions for health plans, specializing in prior authorization automation. The company delivers clinically accurate, transparent AI that integrates directly into existing workflows to reduce administrative burden and accelerate approvals.

Apella

Apella

Apella uses ambient AI and computer vision linked to the EHR to optimize operating room performance. The platform provides real-time visibility, predictive analytics, and automated documentation to help surgical teams serve more patients, reduce delays, and improve OR efficiency.

Apixio

Apixio

Apixio provides AI-powered healthcare data analytics and risk adjustment solutions for health plans and providers. The company specializes in extracting clinical insights from unstructured medical records to improve quality reporting and payment accuracy.

Aspirion

Aspirion

Aspirion helps hospitals unlock high-value revenue from denied and complex claims through AI-powered revenue cycle management. Armed with US-based attorneys, clinicians, and AI engineers, they deploy cutting-edge automation to convert RCM challenges into opportunities.

AssistIQ

AssistIQ

AssistIQ uses AI-powered computer vision to automatically capture surgical supplies and implants in real-time, eliminating manual documentation and improving charge capture accuracy for health systems.

Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.